Deep cultivation of chemical industry to do national industry
Release time:
2020-07-22
sailing against the current deep ploughing chemistry doing national industry
kang litao
general manager of Shanghai beika pharmaceutical technology co., ltd. chemical industry is very ill recently. From Tianjin Port to Lianyungang Port, the Yancheng Tianjiayi 3.21 accident pushed the chemical safety problem to its peak. The accident reflected many problems, such as the storage and management of multi-nitrocellulose, the control of high-pressure hydrogenation reaction, the construction of coal to gas and special operations, the storage of hazardous waste warehouses, the legal representative being the workshop director, the training and loose management of personnel, etc., which made people stand creepy. A week later, Yancheng City announced the permanent closure of Xiangshui Park. At the same time, the thermal power plant of Yancheng Binhai Development Zone, which is 15 kilometers away from Xiangshui 30 , cut off steam from all enterprises. More than 70 enterprises in production were all shut down. The resumption time is unknown and is expected to be at least half a year. At the same time, the park also requested that only 15-20 of the existing 130 enterprises remain.
I went to see the past two factories from Zhejiang and Shanghai, both of which are in the process of 2 project construction. As the investment scale is not hundreds of millions and the land area is less than 100 mu, there is no possibility of further construction. The invested in the early stage has been hit by Shui Piao. At the same time, a large number of factory managers are moving to northern Shaanxi, Inner Mongolia, Ningxia and Gansu. In the public opinion and ideological trend, the local people and outsiders are also full of hostility and criticism to the chemical industry, magnifying the environmental harm of the factory, comparing our factory to a scourge, and the chemical industry is in danger in China.
Why is this happening? As the head of two chemical plants, I often ask myself.
In recent years, I have visited at least 50 parks in China. There are three reasons for this: firstly, investors and shareholders are eager for quick success and instant benefits. A certain variety is launched in a hurry, while investors do not understand the operation characteristics of the chemical, equipment and chemical industries, which leads to being abandoned or shut down halfway due to process problems, industry cycle shutdown, safety and environmental protection, etc, to the integration of resources to bring huge waste and negative impact. The second is the lack of overall planning and operation of the industry. The chemical and chemical industry and its derived pharmaceuticals, pesticides, materials, fuels, electronic chemicals, daily chemicals, etc., have their own development laws, especially the parts involved in chemical reactions, which are technology-intensive, labor-intensive (under the condition that the degree of automation is not high), investment-intensive and resource-intensive industries, the factory needs continuous investment ability and improvement space in personnel, variety, technology, safety, environmental protection and capital, so as to make the factory a global standardized factory. The third is the market and innovation strategy. As the basic and strategic industry of a country, chemistry level determines the industrial level and equipment level of a country. How to set its own benchmark in the world's industrial forest, innovation ability is very important. What does innovation rely on? Rely on strategy and people, strategy determines the market positioning, by people to complete innovation and leadership, which is our industry is now the most lack of two points.
Now, facing the predicament of the chemical and chemical industry, I hope to change the attitude of more people around me towards chemistry in 5-10 and devote myself to chemistry. I also hope to sail against the current in my own work, cultivate chemistry deeply and strengthen the national industry of chemistry. North Carolina Pharmaceutical is an innovative and technological enterprise engaged in chemical pharmacy and pesticide. It has 300 employees and 400 mu factory. It has the full support of its parent company Jianfeng Group and Jianfeng Pharmaceutical. I hope to be a strong chemical and chemical enterprise with my own ideas and actions. Therefore, I must work hard in five aspects:
adhere to political correctness. The chemical industry must not tolerate any opportunism and cutting corners. It must be transparent and open in the specified areas. Employees should be informed and informed, and government and public information should be disclosed and jointly supervised.
Scientific Outlook on Development. Don't rush for success, fully demonstrate and complete due procedures from research and development, project initiation, drug application, safety assessment and environmental assessment, GMP production, market launch and other aspects, strive to become a benchmark enterprise in the industry, maintain the potential to become a leader in the industry, develop green chemistry ecology, and seize due opportunities.
Forward-looking talent view. In our industry, from the quality and research and development of drugs to the safety, environmental protection and automation of the site, all inputs must be controlled by people with corresponding capabilities. How to create an environment to retain talent? In addition to the change of the social environment and the promotion of the overall industry, we also need to give enough care to our employees. In addition to safety and environmental protection, there are also all-round care for life, entertainment, learning and education, marriage and family. At present, we have done a lot of work in joint school training, transportation and accommodation, leisure and entertainment, and we will continue to work hard to give everyone enough care and sense of security.
Fundamental changes in equipment and automation. Most factories are still kettle-type reactions, relying on crowd tactics and high-intensity shifts to save costs, but this has lagged far behind the fully automated production and continuous reaction processes of the same industry abroad, and we have lagged behind in design. Therefore, what needs to be considered now is how to keep materials away from the air, keep employees away from materials, create a good working environment for employees, and at the same time improve the quality and treatment of employees, so as to become a real industrial 3.0-4.0 enterprise.
Further strengthen industry research and integration. At present, many industries have overcapacity, and the integration of many industries after non-standard brings huge opportunities, so we need to study the global market in depth. Ten years of sharpening a sword, leaving enough time for planning and integration is very necessary. We not only want to make profits, but also have strategies and coordination to become the backbone of the chemical industry.
This year marks the 80th anniversary of "May 4th " Movement 100#. I also call on everyone to revitalize the fine chemical national industry with the May 4th spirit of "Patriotism, Progress, Democracy, Science " , so as to make our food, clothing, housing and transportation better, better serve our great health and make the Chinese nation stronger.
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31